| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |